Table 2.
Outcomes.
|
|
Usual care group | Telemedicine group | P value | ||||||
|
|
Preintervention (n=48) | Postintervention (n=46) | P value | Preintervention (n=49) | Postintervention (n=48) | P value |
|
||
| BMI (kg/m2), mean (SD) | 24.2 (4.3) | 3.9 (4.1) | .86 | 24.2 (3.4) | 23.9 (3.3) | .29 | .10 | ||
| Home systolic blood pressure (mmHg), median (95% CI) | 136 (133-139) | 131 (128-134) | .01 | 136 (132-140) | 125 (122-128) | <.001 | .02 | ||
| Home diastolic blood pressure (mmHg), median (95% CI) | 91 (89-93) | 87 (85-89) | .02 | 90 (87-93) | 83 (81-85) | <.001 | .07 | ||
| Home pulse rate (bpm), mean (SD) | 74 (9) | 71 (7) | .46 | 73 (9) | 71 (8) | .08 | .08 | ||
| Systolic blood pressure control rate (%) | 41.3 | 70.0 | <.001 | 47.7 | 85.4 | <.001 | .01 | ||
| Estimated glomerular filtration rate (mL/min/1.73 m2), mean (SD) | 77.3 (13.3) | 76.8 (11.9) | .16 | 74.4 (14.4) | 72.4 (14.4) | .30 | .05 | ||
| Potassium (mEq/L), mean (SD) | 4.1 (0.3) | 4.1 (0.3) | .81 | 4.1 (0.3) | 4.1 (0.3) | .65 | .93 | ||
| Low-density-lipoprotein cholesterol (mg/dL), mean (SD) | 119.2 (28.9) | 110.3 (22.7) | .53 | 123.0 (28.3) | 123.8 (28.6) | .11 | .04 | ||
| Hemoglobin A1c (%), mean (SD) | 5.6 (0.3) | 5.7 (0.3) | .74 | 5.7 (0.3) | 5.7 (0.4) | .60 | .53 | ||
| Plasma aldosterone (pg/mL), median (IQR) | 150 (112-199) | 151 (115-226) | .07 | 167 (136-232) | 171 (139-229) | .54 | .49 | ||
| Plasma renin activity (ng/mL/h), median (IQR) | 0.9 (0.5-1.8) | 1.1 (0.6-3.6) | .02 | 1.2 (0.9-2.0) | 1.9 (1.1-4.8) | .07 | .57 | ||